29 diciembre 2014
Three years after a small number of patients with multiple sclerosis (MS) were treated with high-dose immunosuppressive therapy and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS and had improvements in neurological function, according to a study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/gzT_jjtohGI/141229164854.htm
